Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

Source:http://linkedlifedata.com/resource/pubmed/id/16826479

J. Infect. Dis. 2006 Aug 1 194 3 316-24

Download in:

View as

General Info

PMID
16826479